Related Experiment Video
Updated: Apr 1, 2026

07:49
Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
3.4K
Mitochondrial Metabolism in Breast Cancer.
Qian Hu1, Zhihao Luo1, Weixi Yuan1
1Pharmacy and Pharmacology, University of South China, 421001 Hengyang, Hunan, China.
Frontiers in Bioscience (Landmark Edition)
|March 31, 2026
Summary
Mitochondrial metabolism fuels breast cancer progression and resistance. This review explores metabolic strategies and challenges for developing precision medicine to overcome therapeutic hurdles in breast cancer treatment.
Area of Science:
- Oncology
- Metabolic Research
- Biochemistry
Background:
- Breast cancer is a leading global malignancy in women.
- Mitochondrial metabolic dysregulation is a key driver of breast cancer progression and therapeutic resistance.
- Current therapeutic strategies face challenges due to metabolic heterogeneity and drug resistance.
Purpose of the Study:
- To systematically review mitochondrial metabolic mechanisms in breast cancer subtypes.
- To emphasize the spatial network regulatory functions of mitochondrial metabolism.
- To critically evaluate combined therapeutic strategies targeting metabolic vulnerabilities.
Main Methods:
- Systematic literature synthesis of mitochondrial metabolism in breast cancer.
- Analysis of spatial network regulatory functions.
- Evaluation of combined therapeutic strategies.
Main Results:
- Mitochondrial metabolism significantly influences breast cancer subtypes and progression.
- Metabolic heterogeneity and plasticity present major therapeutic challenges.
- Targeting mitochondrial metabolism offers potential for novel treatments.
Conclusions:
- Understanding mitochondrial metabolism is crucial for breast cancer treatment.
- Novel therapeutic frameworks are needed to address metabolic challenges.
- Precision medicine approaches targeting mitochondrial metabolism hold promise for improved outcomes.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
7.4K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.4K
Electron Transport Chain: Complex I and II
19.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.6K
Mitochondria
21.4K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
21.4K
Mitochondrial Membranes
17.8K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
17.8K
What is Metabolism?
136.1K
Overview
136.1K
mTOR Signaling and Cancer Progression
5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.1K

